e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
New mechanisms in airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MKK3 is expressed in cells from patients with allergic asthma
T. Holand, Y. Riffo-Vasquez, D. Spina, B. O‘Connor, F. Woisin, M. Barber, K. Bacon, C. Rohlff, C. Page (London, Slough, Oxon, United Kingdom; Wuppertal, Germany; San Diego, United States Of America)
Source:
Annual Congress 2011 - New mechanisms in airway disease
Session:
New mechanisms in airway disease
Session type:
Thematic Poster Session
Number:
709
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Holand, Y. Riffo-Vasquez, D. Spina, B. O‘Connor, F. Woisin, M. Barber, K. Bacon, C. Rohlff, C. Page (London, Slough, Oxon, United Kingdom; Wuppertal, Germany; San Diego, United States Of America). MKK3 is expressed in cells from patients with allergic asthma. Eur Respir J 2011; 38: Suppl. 55, 709
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
TNFAIP3/A20 expression in allergic asthma
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
The role of MKK3 in allergic and non-allergic inflammatory responses in the lung
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Recruitment of eosinophils and increased expression of mast cells tryptase in the bronchial mucosa of patients with allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002
Co-cultured with atopic eosinophil and airway epithelial cells upregulate phosphorylated smad2
Source: Eur Respir J 2007; 30: Suppl. 51, 496s
Year: 2007
Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Gamma/delta T cells regulate airways disease during rhinovirus-induced asthma exacerbations
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
MiR-1165-3p downregulated in Th2 cells inhibits Th2 differentiation in allergic asthma by targeting PPM1A
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
In vivo allergen-activated inflammatory eosinophils reduced airway smooth muscle cells apoptosis in allergic asthma patients
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Activin-A induces human regulatory T cells that control allergic asthma
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020
How cultured epithelial cells from asthma and COPD patients deal with pathogens: defective anti-rhinovirus responses in asthma
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008
Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
The airway inflammatory response in allergic mice is downregulated by budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 265s
Year: 2001
Alveolar mast cell expression of FcεRI differs between allergic asthma and rhinitis
Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways
Year: 2011
Plasma cells in the airways express neurotrophins and neurotrophin-receptors in a mouse model of chronic allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Improvement of allergic asthma symptoms by targeting STAT6 with siRNA
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept